218 related articles for article (PubMed ID: 37143970)
1. The role of booster vaccination in decreasing COVID-19 age-adjusted case fatality rate: Evidence from 32 countries.
Zhou C; Wheelock ÅM; Zhang C; Ma J; Dong K; Pan J; Li Z; Liang W; Gao J; Xu L
Front Public Health; 2023; 11():1150095. PubMed ID: 37143970
[TBL] [Abstract][Full Text] [Related]
2. Country-specific determinants for COVID-19 case fatality rate and response strategies from a global perspective: an interpretable machine learning framework.
Zhou C; Wheelock ÅM; Zhang C; Ma J; Li Z; Liang W; Gao J; Xu L
Popul Health Metr; 2024 Jun; 22(1):10. PubMed ID: 38831424
[TBL] [Abstract][Full Text] [Related]
3. The confounded crude case-fatality rates (CFR) for COVID-19 hide more than they reveal-a comparison of age-specific and age-adjusted CFRs between seven countries.
Green MS; Peer V; Schwartz N; Nitzan D
PLoS One; 2020; 15(10):e0241031. PubMed ID: 33085731
[TBL] [Abstract][Full Text] [Related]
4. Case-fatality rate of SARS-CoV-2 infection during the third and fifth epidemic waves in Spain: Impact of vaccination.
Martín-Sánchez V; Ruiz-Garcia A; Vitelli-Storelli F; Serrano-Cumplido A; Barquilla-Garcia A; Micó-Pérez RM; Olmo-Quintana V; Calderón-Montero A; Segura-Fragoso A
Semergen; 2023 Oct; 49(7):102026. PubMed ID: 37356278
[TBL] [Abstract][Full Text] [Related]
5. The age structure of cases as the key of COVID-19 severity: Longitudinal population-based analysis of European countries during 150 days.
Hulíková Tesárková K; Dzúrová D
Scand J Public Health; 2022 Aug; 50(6):738-747. PubMed ID: 34923870
[TBL] [Abstract][Full Text] [Related]
6. Pandemic preparedness and COVID-19: an exploratory analysis of infection and fatality rates, and contextual factors associated with preparedness in 177 countries, from Jan 1, 2020, to Sept 30, 2021.
COVID-19 National Preparedness Collaborators
Lancet; 2022 Apr; 399(10334):1489-1512. PubMed ID: 35120592
[TBL] [Abstract][Full Text] [Related]
7. Time-series comparison of COVID-19 case fatality rates across 21 countries with adjustment for multiple covariates.
Kim Y; Kim BI; Tak S
Osong Public Health Res Perspect; 2022 Dec; 13(6):424-434. PubMed ID: 36617548
[TBL] [Abstract][Full Text] [Related]
8. Estimating national-level measles case-fatality ratios in low-income and middle-income countries: an updated systematic review and modelling study.
Sbarra AN; Mosser JF; Jit M; Ferrari M; Ramshaw RE; O'Connor P; Krause LK; Rogowski ELB; Portnoy A
Lancet Glob Health; 2023 Apr; 11(4):e516-e524. PubMed ID: 36925172
[TBL] [Abstract][Full Text] [Related]
9. The Contribution of the Age Distribution of Cases to COVID-19 Case Fatality Across Countries : A Nine-Country Demographic Study.
Sudharsanan N; Didzun O; Bärnighausen T; Geldsetzer P
Ann Intern Med; 2020 Nov; 173(9):714-720. PubMed ID: 32698605
[TBL] [Abstract][Full Text] [Related]
10. Global COVID-19 case fatality rates influenced by inequalities in human development and vaccination rates.
Nuhu K; Humagain K; Alorbi G; Thomas S; Blavos A; Placide V
Discov Soc Sci Health; 2022; 2(1):20. PubMed ID: 36340573
[TBL] [Abstract][Full Text] [Related]
11. Delay-adjusted age- and sex-specific case fatality rates for COVID-19 in South Korea: Evolution in the estimated risk of mortality throughout the epidemic.
Newall AT; Leong RNF; Nazareno A; Muscatello DJ; Wood JG; Kim WJ
Int J Infect Dis; 2020 Dec; 101():306-311. PubMed ID: 33011281
[TBL] [Abstract][Full Text] [Related]
12. Monitoring trends and differences in COVID-19 case-fatality rates using decomposition methods: Contributions of age structure and age-specific fatality.
Dudel C; Riffe T; Acosta E; van Raalte A; Strozza C; Myrskylä M
PLoS One; 2020; 15(9):e0238904. PubMed ID: 32913365
[TBL] [Abstract][Full Text] [Related]
13. Finding the real COVID-19 case-fatality rates for SAARC countries.
Shah MRT; Ahammed T; Anjum A; Chowdhury AA; Suchana AJ
Biosaf Health; 2021 Jun; 3(3):164-171. PubMed ID: 33748737
[TBL] [Abstract][Full Text] [Related]
14. Differences in incidence and fatality of COVID-19 by SARS-CoV-2 Omicron variant versus Delta variant in relation to vaccine coverage: A world-wide review.
Wang C; Liu B; Zhang S; Huang N; Zhao T; Lu QB; Cui F
J Med Virol; 2023 Jan; 95(1):e28118. PubMed ID: 36056540
[TBL] [Abstract][Full Text] [Related]
15. Differential health impact of intervention programs for time-varying disease risk: a measles vaccination modeling study.
Portnoy A; Hsieh YL; Abbas K; Klepac P; Santos H; Brenzel L; Jit M; Ferrari M
BMC Med; 2022 Mar; 20(1):113. PubMed ID: 35260139
[TBL] [Abstract][Full Text] [Related]
16. Case fatality rates of COVID-19 during epidemic periods of variants of concern: A meta-analysis by continents.
Xia Q; Yang Y; Wang F; Huang Z; Qiu W; Mao A
Int J Infect Dis; 2024 Apr; 141():106950. PubMed ID: 38309460
[TBL] [Abstract][Full Text] [Related]
17. The impact of COVID-19 vaccination on case fatality rates in a city in Southern Brazil.
Passarelli-Araujo H; Pott-Junior H; Susuki AM; Olak AS; Pescim RR; Tomimatsu MFAI; Volce CJ; Neves MAZ; Silva FF; Narciso SG; Aschner M; Paoliello MMB; Urbano MR
Am J Infect Control; 2022 May; 50(5):491-496. PubMed ID: 35192917
[TBL] [Abstract][Full Text] [Related]
18. Racial-ethnic disparities in case fatality ratio narrowed after age standardization: A call for race-ethnicity-specific age distributions in State COVID-19 data.
Pathak I; Choi Y; Jiao D; Yeung D; Liu L
medRxiv; 2020 Oct; ():. PubMed ID: 33024984
[TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2 Vaccination Coverage and Key Public Health Indicators May Explain Disparities in COVID-19 Country-Specific Case Fatality Rate Within European Economic Area.
Papadopoulos VP; Emmanouilidou A; Yerou M; Panagaris S; Souleiman C; Varela D; Avramidou P; Melissopoulou E; Pappas C; Iliadou Z; Piperopoulos I; Somadis V; Partsalidis A; Metaxa E; Feresiadis I; Filippou D
Cureus; 2022 Mar; 14(3):e22989. PubMed ID: 35415037
[TBL] [Abstract][Full Text] [Related]
20. Sex differences in the case-fatality rates for COVID-19-A comparison of the age-related differences and consistency over seven countries.
Green MS; Nitzan D; Schwartz N; Niv Y; Peer V
PLoS One; 2021; 16(4):e0250523. PubMed ID: 33914806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
